Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$220.68
-2.14-0.96%
Last update: Oct 2, 1:20 PM
$223.50
0.680.31%
Biogen Inc (BIIB) Stock Price, Quote, News & History
BIIBNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Biogen (NASDAQ:BIIB) through any online brokerage.
Other companies in Biogen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Biogen has a consensus price target of $221.68.
The stock price for Biogen (NASDAQ: BIIB) is $220.675 last updated October 2, 2026 at 1:20 PM EDT.
There are no upcoming dividends for Biogen.
Biogen does not have any upcoming earnings scheduled.
There is no upcoming split for Biogen.
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
